or
forgot password
  • cancer clinical trials in sacramento, CA

  • S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
    University of California Davis Medical Center
    Sacramento, California 95817
    Leukemia
    Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Kaiser Permanente Medical Center - Oakland
    Lymphoma
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Anemia, Head and Neck Cancer
    Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
    University of California Davis Medical Center
    Sacramento, California 95817
    Leukemia
    Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
    University of California Davis Cancer Center
    Sacramento, California 95817
    Unspecified Adult Solid Tumor, Protocol Specific
    Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
    University of California Davis Cancer Center
    Sacramento, California 95817
    Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Head and Neck Cancer
    Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
    University of California Davis Medical Center
    Sacramento, California 95817
    Cardiac Toxicity, Lymphoma
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Leukemia
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    University of California Davis Cancer Center
    Sacramento, California 95817
    Gastrointestinal Stromal Tumor
    S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
    University of California Davis Medical Center
    Sacramento, California 95817
    Pancreatic Cancer
    S9923 R115777 in Treating Patients With Advanced Colorectal Cancer
    University of California Davis Medical Center
    Sacramento, California 95817
    Colorectal Cancer
    S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
    University of California Davis Medical Center
    Sacramento, California 95817
    Multiple Myeloma
    Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
    University of California Davis Cancer Center
    Sacramento, California 95817
    Unspecified Adult Solid Tumor, Protocol Specific
    Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
    University of California Davis Cancer Center
    Sacramento, California 95817
    Prostate Cancer
    S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    Sutter Cancer Center
    Sacramento, California 95816
    Leukemia, Lymphoma
    S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
    University of California Davis Cancer Center
    Sacramento, California 95817
    Leukemia
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Prostate Cancer
    Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Colorectal Cancer
    SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Kidney Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Brain and Central Nervous System Tumors
    UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
    University of California Davis Cancer Center
    Sacramento, California 95817
    Unspecified Adult Solid Tumor, Protocol Specific
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Lung Cancer
    S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
    University of California Davis Medical Center

    Trial Locations
    University of California Davis Medical Center
    University of California Davis Cancer Center
    Lung Cancer
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
    University of California Davis Cancer Center

    Trial Locations
    University of California Davis Cancer Center
    Kaiser Permanente Medical Center - Sacramento
    Sarcoma
    Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
    University of California Davis Cancer Center
    Sacramento, California 95817
    Cancer-related Problem/Condition, Head and Neck Cancer, Pain
    Screening and Diagnostic Trial to Compare the Effectiveness of Two Types of Mammography in Detecting Breast Cancer in Women
    University of California Davis Cancer Center
    Sacramento, California 95817
    Breast Cancer
    Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Lung Cancer
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
    University of California Davis Medical Center

    Trial Locations
    University of California Davis Medical Center
    Sutter Cancer Center
    Leukemia
    S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
    University of California Davis Medical Center
    Sacramento, California 95817
    Esophageal Cancer, Gastric Cancer
    S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
    University of California Davis Medical Center
    Sacramento, California 95817
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
    University of California Davis Medical Center
    Sacramento, California 95817
    Lung Cancer
    S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Breast Cancer
    BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
    University of California Davis Cancer Center
    Sacramento, California 95817
    Prostate Cancer
    S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
    University of California Davis Cancer Center
    Sacramento, California 95817
    Leukemia, Myelodysplastic Syndromes
    Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer
    University of California Davis Medical Center

    Trial Locations
    University of California Davis Medical Center
    University of California Davis Cancer Center
    Kidney Cancer
    Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
    Kaiser Permanente Medical Center - Oakland
    Sacramento, California 95825
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    University of California Davis Medical Center

    Trial Locations
    University of California Davis Medical Center
    Sutter Cancer Center
    Brain and Central Nervous System Tumors